📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Health benefits of glucosinolates and cruciferous vegetables

Lead Research Organisation: QUADRAM INSTITUTE BIOSCIENCE
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Glucosinolates are ß-thioglucoside-N-hydroxysulfates that accumulate in plants of the order Brassicales that include cruciferous vegetable and salad crops. Epidemiological studies have shown that diets rich in cruciferous vegetables are associated with benefits to health, but the underlying mechanisms are largely unknown. This project has two main objectives Firstly, to quantify how genetic and environmental factors interact to determine the level of glucosinolates and other bioactive compounds that accumulate in broccoli, and, secondly, to elucidate how consuming broccoli and other glucosinolate-containing functional foods affect the expression of biomarkers of health and healthy aging in humans, and identify the underlying molecular mechanisms. Metabolomic and transcriptomic approaches will be used to identify differences between broccoli cultivars with different levels of glucosinolates, and used to develop further broccoli genotypes for human intervention studies. Emphasis will be on the partitioning of sulphur between primary and secondary metabolism. This work will be complemented with elucidating the biological activity of glucosinolate degradation products and other bioactive compounds from broccoli with the use of a variety of model systems, and with short and longer term human intervention studies. Of particular interest is how isothiocyanates can perturb cell signalling pathways to reduce the production of pro-inflammatory cytokines.

Planned Impact

unavailable

Publications

10 25 50

publication icon
Folkard DL (2015) Effect of Sulforaphane on NOD2 via NF-?B: implications for Crohn's disease. in Journal of inflammation (London, England)

 
Description This project explored how dietary consumption 4-methylsulphinylbutyl glucosinolates and its derivative 4-methylsulphinylbutyl isothiocyanate which are obtained from broccoli may enhance health. The project used a combination of human cell models and human dietary intervention studies. The main finding from these studies is that the most likely mode of action is subtle effects on many redox sensitive enzymes that modulate central pathways of metabolism. One consequence of this is diets rich in these compounds may reduce LDL cholesterol. We now consider that sulforaphane's main mode of action is during first pass effects on liver metabolism.

We have further shown that regular consumption of very high glucoraphanin broccoli can lead to improved regulation of blood glucose levels and suppresses changes in gene expression in the prostate of 'at risk' men associated with carcinogenesis
Exploitation Route The results of this project have more general implications for the manner by which diets rich in sulphur rich compounds found in Brassica and Allium may maintain and promote health. This information could be exploited by the food industry to develop novel processed products, and also inform public health by strengthen the evidence that certain fruits and vegetables may reduce risk of chronic disease

Germplasm from this programme of research has been licensed to the commercial sector and to a newly formed Spin-out company
Sectors Agriculture

Food and Drink

URL http://www.superbroccoli.info
 
Description The outcome of this project is being used by the commercial sector to commercialised new cultivars of broccoli sold under the tradename 'Beneforte broccoli' The mechanistic evidence generate by this project will form part of a submission to EFSA to obtain an approved health claim on Beneforte broccoli. The programme has evaluated the use of high glucoraphanin broccoli in human studies concerned with cholesterol and arthritis, and mechanistic studies with cell models investigating how sulforaphane can modulate lipid metabolism and inflammatory responses. The results of this project has led to the formation of a spin out company - The Smarter Food Company - that has received significant investment from the private sector and is currently negotiating for exclusive license to the high glucoraphanin broccoli lines to be used in processed food products Moreover, the results have also led to improved dietary advice concerning the importance of cruciferous vegetables in the diet and the maintenance and promotion of good health
First Year Of Impact 2019
Sector Agriculture, Food and Drink,Healthcare
Impact Types Societal

Economic

 
Title S-METHYLCYSTEINE SULFOXIDE FOR PROSTATE CANCER PREVENTION AND TREATMENT 
Description The present invention relates to S-methylcysteine sulfoxide and compositions thereof for use in the treatment or prevention of prostate cancer. It also relates to analogues, derivatives or metabolites of S-methylcysteine sulfoxide for use in the treatment or prevention of prostate cancer. Compositions of S-methylcysteine sulfoxide or its analogues, derivatives or metabolites may be provided for oral consumption, for example as a pharmaceutical composition, a medicament or a food composition. 
IP Reference WO2017163081 
Protection Patent application published
Year Protection Granted 2017
Licensed No
Impact N/A
 
Title BOBs clinical trial 
Description A food product that deliver physiological active concentrations of the bioactive sulforaphane to the systemic circulation 
Type Preventative Intervention - Nutrition and Chemoprevention
Current Stage Of Development Early clinical assessment
Year Development Stage Completed 2016
Development Status Actively seeking support
Clinical Trial? Yes
Impact A food products that has been shown to deliver physiological active levels of the bioactive compound sulforaphane to the systemic circulation 
URL https://clinicaltrials.gov/show/NCT023300324
 
Title ESCAPE clinical trial 
Description A novel food products that delivers high levels of the bioactive compound glucoraphanin in a food matrix that inhibits changes in gene expression in prostate tissue that are associated with cancer progression 
Type Preventative Intervention - Nutrition and Chemoprevention
Current Stage Of Development Early clinical assessment
Year Development Stage Completed 2018
Development Status Actively seeking support
Clinical Trial? Yes
Impact The products is being developed through a spin out company 
URL https://clinicaltrials.gov/show/NCT01950143
 
Title SAP clinical trial 
Description A food product that delivers high levels of the bioactive compound S-methylcysteine sulfoxide which accumulates in prostate tissue of men with organ confined prostate cancer 
Type Preventative Intervention - Nutrition and Chemoprevention
Current Stage Of Development Early clinical assessment
Year Development Stage Completed 2018
Development Status Actively seeking support
Clinical Trial? Yes
Impact A food product that delivers S-methyl cysteine sulfoxide that accumulates in prostate tissue and may reduce risk of aggressive prostate cancer. A patent has been filed. 
URL https://clinicaltrials.gov/show/NCT02821728
 
Company Name The Smarter Food Company 
Description The Smarter Food Company develops food that aims to help with the reduction in type-2 diabetes. 
Year Established 2018 
Impact The company has recently been established. It has received investment from private equity funds an a grant from Innovate UK. It s currently engaged with developing food products that will enter clinical trials towards end of 2019
Website https://smarternaturally.com/